Studies with 35S-labelled DL-penicillamine in patients with Wilson's disease.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001345:Autoradiography; D001797:Blood Protein Electrophoresis; D001826:Body Fluids / Q000032:analysis; D002854:Chromatography, Paper; D005260:Female; D005374:Filtration; D006527:Hepatolenticular Degeneration / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007408:Intestinal Absorption; D007668:Kidney / Q000378:metabolism; D008297:Male; D010396:Penicillamine / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D011485:Protein Binding; D012709:Serum Albumin; D013460:Sulfur Isotopes
D012709:Serum Albumin; D013460:Sulfur Isotopes; D010396:Penicillamine